FDA Investigator Jazmine N Still

Jazmine N Still has conducted inspections on 43 sites in 1 countries as of 14 Sep 2021. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
43
Last Inspection Date:
14 Sep 2021
Investigator Role:
FDA Investigator
Redica ID:
100003577
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Jazmine N Still:
Alan L Truong, Allison C Hunter, Amy L Mccarthy, Andrew A Hoopes, Andrew J Barrowcliff, Andrew J Lang, Andrew T Todd, Andria L Kuhlman, Anna M Brannen, Annemarie H Cochran, Annemarie Kleiza, Anthony R Bucks, Ashley A Mutawakkil, Avital A Shimanovich, Bailey A Uetrecht, Benjamin J Dastoli, Benjamin J Smith, Benjamin P Stewart, Bijoy Panicker, Bo Chi, PhD, Brenda C Hamilton, Brent M Dehaan, Brett R Havranek, Brittany D Terhar, Brittany M Kershaw, Brooke K Higgins, Brooke K Seeman, Carl A Huffman, III, Charisse K Green, Christine A Harman, PhD, Christopher D Snyder, Christopher T Middendorf, Cody D Rickman, Colleen Thomas, PhD, Damaris Y Hernandez, Darla J Christopher, Darren S Morgan, David J Eide, Dell S Moller, Diane M Fresch, Donald L Myers, Dorathy M Eischen, Douglas A Campbell, Dr. Robert C Horan, MD, Dr. Zhou Chen (nmi), MD PhD, Edmund F Mrak, Jr, Edward R Kay, Elizabeth Ll Edwards, Emest F Bizjak, Eric M Mueller, PharmD, Eric M Padgett, Frederick M Lochner, Gary J Lehr, Geneve M Maxwell, Geneve M Parks, Geoffrey K Kilili, Gwyn G Dickinson, Hector A Carrero, Helen Y Saccone, Howard Anderson, PhD, Hugh M Mcclure, II, Jacob G Lutz, Jacqueline Mdiaz Albertini, James A Liubicich, James I Giefer, Janet B Abt, Janet L Bowen, Javonica F Penn, Jazmine N Brown, Jeffrey A Sommers, Jeffrey D Meng, Jennifer L Sheehan, Joohi Castelvetere, Joseph A Piechocki, Joseph R Lambert, Joshua P Wireman, Joshua S Hunt, Juanita P Versace, Juliann N Roberts, Karen M Kondas, Kathleen D Culver, Kathryn J Mccarty, Kelly K Nachtigal, Ken L Bowers, Kevin D Kallander, Kimberly A Joseph, Lakshmi Narasimhan, PhD, Larry K Austin, Laureen M Geniusz, Lauren N Howard, Lauren N Smith, Lawrence W Farina, Lewis K Antwi, Lindsey M Schwierjohann, Lisa B Orr, Lisa L Flores, Lisa M Marko, Logan T Williams, Margaret A Smithers, Maria Gutierrez Lugo, PhD, Maribeth G Niesen, Mary B Sheets, Mary E Storch, Matthew B Casale, Matthew M Schuckmann, Matthew R Sleeter, Meisha R Sampson, Meisha Waters, Melissa J Garcia, Michael E Clark, Michael G Truchan, Michael P Sheehan, Michele L Forster, PhD, Michele L Obert, Michele Perry Williams, Mishelle L Harriger, Monica M Mcclure, Muna Algharibeh, Nancy G Schmidt, Nancy L Neiger, Nicholas L Paulin, Omotunde O Osunsanmi, Parul M Patel, Paula A Trost, Phillip M Pontikos, Pifer, Ralph H Vocque, Rebecca E Dombrowski, Richard L Rutherford, Rita K Kabaso, Robert J Ham, Robert M Barbosa, Rosanna M Goodrich, Roy C Stephens, Samuel A Hamblin, Sarah A Meehan, Sarah A Wangseng, Sarah E Rhoades, Scott A Golladay, Shafiq S Ahadi, Shari L Kahn, Shirley J Berryman, Sidney B Priesmeyer, Simone E Pitts, Siobhan G Taylor, Stephen J Kilker, Steven D Kehoe, Steven E Bowen, PhD, Steven P Donald, Susan M Jackson, Susan T Hadman, Susanna E Ford, Tara L Breckenridge, Tara L Greene, Thomas E Friel, Thomas J Mooney, Ucheabuchi Cchudi Nwankwor, Walsworth, Wayne D Mcgrath, Wen Ning Chan (Sally), Zhenzhen Liu, PhD, Zi Qiang Gu

Jazmine N Still's Documents

Publish Date Document Type Title
April, 2019 EIR Akron Coating & Adhesives - EIR, 2019-04-10
June, 2017 FDA 483 Gipsco Investment Corp - Form 483, 2017-06-09
May, 2017 FDA 483 Nestle USA - Form 483, 2017-05-04
February, 2018 FDA 483 RC Compounding Services, LLC - Form 483, 2018-02-16
February, 2017 FDA 483 Krispy Kreme Doughnut Corporation #325 - Form 483, 2017-02-17
July, 2019 EIR Charles River Laboratories Cleveland, Inc. - EIR, 2019-07-08
February, 2022 FDA 483 Altaire Pharmaceuticals Inc. - Form 483, 2022-02-11
March, 2017 FDA 483 RC Outsourcing, LLC - Form 483, 2017-03-31
July, 2018 FDA 483 Nutrishare Inc - Form 483, 2018-07-26
February, 2022 FDA 483 Response Altaire Pharmaceuticals Inc. - Form 483R, 2022-03-10
August, 2021 FDA 483 Ranier's Compounding Laboratory - Form 483, 2021-08-16
May, 2017 EIR GOJO Industries, Inc - EIR, 2017-05-09
April, 2018 FDA 483 Church & Dwight Co., Inc. - Form 483, 2018-04-27
June, 2021 FDA 483 Ionetix - Form 483, 2021-06-04
January, 2020 EIR Hospira, Inc. - EIR, 2020-01-17
April, 2019 FDA 483 Akron Coating & Adhesives - Form 483, 2019-04-10
January, 2019 EIR Olon USA LLC - EIR, 2019-01-22
February, 2019 FDA 483 Buderer Drug Company - Form 483, 2019-02-14
May, 2018 FDA 483 Exelead, Inc. - Form 483, 2018-05-15
March, 2018 FDA 483 OAKWOOD LABORATORIES, L.L.C. - Form 483, 2018-03-29
August, 2019 FDA 483 Eden's Answers Inc - Form 483, 2019-08-14
October, 2019 FDA 483 Valtronic Technologies Inc. - Form 483, 2019-10-29
February, 2020 EIR Charles River Laboratories Cleveland, Inc. - EIR, 2020-02-19
July, 2017 FDA 483 Buderer Drug Company Inc - Form 483, 2017-07-24
January, 2020 FDA 483 Response Hospira, Inc. - Form 483R, 2020-02-10
January, 2020 FDA 483 Hospira, Inc. - Form 483, 2020-01-17
March, 2020 FDA 483 Cosmax Usa, Corporation - Form 483, 2020-03-17
December, 2017 FDA 483 CIL Isotope Separations, LLC - Form 483, 2017-12-13
June, 2019 FDA 483 RXQ Compounding LLC - Form 483, 2019-06-06
December, 2018 FDA 483 LGM PHARMA, LLC - Form 483, 2018-12-04

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more